Dendreon (DNDN) Sees Action on Renewed Takeover Speculation
Tweet Send to a Friend
Get Alerts DNDN Hot Sheet
Down)
Trade DNDN Now!
They're back...
That is takeover rumors on Provenge maker Dendreon (Nasdaq: DNDN).
Today's rumors are vague and come from what would seem to be unreliable sources. Nonetheless, the chatter is enough to move the stock 1.2 percent higher on the session.
The company's new CEO hire John Johnson brings with him an M&A background, having sold ImClone to Eli Lilly in the past, so takeover talk sprouts up quickly and frequently on the name.
In the recent past, Amgen (Nasdaq: AMGN) has been mentioned as a possible suitor.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
That is takeover rumors on Provenge maker Dendreon (Nasdaq: DNDN).
Today's rumors are vague and come from what would seem to be unreliable sources. Nonetheless, the chatter is enough to move the stock 1.2 percent higher on the session.
The company's new CEO hire John Johnson brings with him an M&A background, having sold ImClone to Eli Lilly in the past, so takeover talk sprouts up quickly and frequently on the name.
In the recent past, Amgen (Nasdaq: AMGN) has been mentioned as a possible suitor.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Liberty Global (LBTYA) Interested in Kabel Deutschland - FT
- Amgen (AMGN) Boosts Cytokinetics (CYTK) to 7.58%
- Tesla (TSLA) Ramps Higher (GM)
Create E-mail Alert Related Categories
Rumors
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
